Yunnan Botanee Bio-Technology Group Co.LTD
SZSE:300957.SZ
72.28 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 2,091.46 | 2,514.296 | 2,034.634 | 751.952 | 527.232 | 251.146 | 262.923 |
| Short Term Investments
| 1,548.357 | 1,433.635 | 781.147 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 3,639.817 | 3,947.931 | 2,815.781 | 751.952 | 527.232 | 251.146 | 262.923 |
| Net Receivables
| 899.99 | 570.465 | 387.825 | 365.41 | 199.988 | 136.997 | 76.823 |
| Inventory
| 904.413 | 670.748 | 463.269 | 253.749 | 198.766 | 259.934 | 115.887 |
| Other Current Assets
| 78.357 | 525.888 | 1,558.151 | 20.064 | 9.47 | 7.744 | 3.543 |
| Total Current Assets
| 5,522.577 | 5,715.033 | 5,225.027 | 1,391.175 | 935.455 | 655.82 | 459.176 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 836.662 | 665.364 | 431.96 | 109.294 | 61.414 | 54.759 | 15.417 |
| Goodwill
| 413.741 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 193.109 | 77.945 | 64.586 | 55.164 | 45.82 | 23.145 | 2.734 |
| Goodwill and Intangible Assets
| 606.849 | 77.945 | 64.586 | 55.164 | 45.82 | 23.145 | 2.734 |
| Long Term Investments
| 307.486 | -1,350.859 | 41.021 | 20.356 | 22.59 | 20.373 | 15.107 |
| Tax Assets
| 127.917 | 51.235 | 15.584 | 13.354 | 10.412 | 6.962 | 6.678 |
| Other Non-Current Assets
| 140.224 | 1,560 | 34.314 | 12.526 | 8.146 | 2.913 | 2.728 |
| Total Non-Current Assets
| 2,019.14 | 1,003.684 | 587.464 | 210.694 | 148.382 | 108.152 | 42.666 |
| Total Assets
| 7,541.716 | 6,718.717 | 5,812.491 | 1,601.869 | 1,083.837 | 763.972 | 501.842 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 334.371 | 372.373 | 361.61 | 134.836 | 88.371 | 65.425 | 36.577 |
| Short Term Debt
| 213.482 | 62.416 | 48.907 | 18.154 | 14.957 | -28.84 | -14.449 |
| Tax Payables
| 105.223 | 119.41 | 121.571 | 79.954 | 72.089 | 33.88 | 69.651 |
| Deferred Revenue
| 50.054 | 58.116 | 485.161 | 36.504 | 177.778 | 28.84 | 14.449 |
| Other Current Liabilities
| 693.308 | 498.962 | 4.069 | 201.695 | 15.054 | 238.826 | 197.054 |
| Total Current Liabilities
| 1,291.214 | 991.867 | 899.747 | 391.19 | 296.161 | 304.252 | 233.631 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 4.7 | 50.945 | 76.292 | 53.155 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 82.863 | 55.575 | 6.299 | 7.414 | 24.52 | 7.313 | 3.947 |
| Deferred Tax Liabilities Non-Current
| 75.239 | 8.055 | 1.686 | -53.155 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -10.979 | 10.5 | 50 | 1.448 | 2.138 | 1.542 | 1.822 |
| Total Non-Current Liabilities
| 151.822 | 125.075 | 134.277 | 8.861 | 26.658 | 8.855 | 5.768 |
| Total Liabilities
| 1,443.036 | 1,116.941 | 1,034.025 | 400.052 | 322.819 | 313.107 | 239.399 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 423.6 | 423.6 | 423.6 | 360 | 360 | 49.008 | 47.511 |
| Retained Earnings
| 2,490.099 | 2,071.587 | 1,329.978 | 726.48 | 330.41 | 332.319 | 193.768 |
| Accumulated Other Comprehensive Income/Loss
| 211.128 | 211.081 | 3,001.626 | 86.816 | 80.356 | 63.813 | 13.653 |
| Other Total Stockholders Equity
| 2,736.166 | 2,846.005 | 0 | 25.708 | -14.47 | 0 | 0 |
| Total Shareholders Equity
| 5,860.994 | 5,552.273 | 4,755.204 | 1,199.004 | 756.297 | 445.14 | 254.932 |
| Total Equity
| 6,015.818 | 5,601.776 | 4,778.467 | 1,201.817 | 761.019 | 450.865 | 262.443 |
| Total Liabilities & Shareholders Equity
| 7,541.716 | 6,718.717 | 5,812.491 | 1,601.869 | 1,083.837 | 763.972 | 501.842 |